Alpha-lipoic acid is often described as a powerful antioxidant that may support glucose metabolism, nerve health and the body’s natural antioxidant defences.
Some sources go much further, claiming that alpha-lipoic acid can detoxify heavy metals, inhibit cancer, treat multiple sclerosis or prevent diabetic eye disease. Although laboratory research is interesting, many of these stronger claims have not been established in well-controlled human studies.
This article examines what alpha-lipoic acid is, its potential benefits, how it is used and where the evidence remains uncertain.
What Is Alpha-Lipoic Acid?
Alpha-lipoic acid—abbreviated to ALA and also known as lipoic acid or thioctic acid—is a naturally occurring organosulphur compound.
It should not be confused with alpha-linolenic acid, which is an omega-3 fatty acid and is also abbreviated to ALA.
The body produces small amounts of alpha-lipoic acid. Inside cells, it functions as a cofactor for mitochondrial enzymes involved in converting nutrients into usable energy.
Alpha-lipoic acid is also present in foods, including:
-
Red meat
-
Organ meats
-
Spinach
-
Broccoli
-
Brussels sprouts
-
Tomatoes
Food contains relatively small amounts, generally bound to proteins. Supplements provide considerably larger and more concentrated quantities than would normally be obtained from food.
Why Is Alpha-Lipoic Acid Considered an Antioxidant?
Normal metabolism continuously produces reactive oxygen species, sometimes called free radicals. Environmental factors such as pollution, cigarette smoke and excessive ultraviolet exposure may also contribute to oxidative stress.
Oxidative stress occurs when the production of reactive compounds exceeds the body’s ability to manage them. Excessive oxidative stress can damage cellular membranes, proteins, mitochondria and DNA.
Alpha-lipoic acid and its reduced form, dihydrolipoic acid, participate in redox reactions and have antioxidant properties. Laboratory evidence suggests that this system may:
-
Interact with certain reactive oxygen species
-
Support glutathione production
-
Participate in the regeneration of vitamins C and E
-
Bind some metal ions under experimental conditions
-
Support cellular antioxidant pathways
The relationship is more complex than describing antioxidants as simple “sponges” that absorb free radicals. The body maintains an interconnected antioxidant network involving enzymes, glutathione, vitamins and other protective systems.[1,2]
Potential Benefits of Alpha-Lipoic Acid
1. Supports the body’s antioxidant defences
One of alpha-lipoic acid’s best-known properties is its involvement in antioxidant defence.
Alpha-lipoic acid may help support glutathione, an important antioxidant produced by the body. Glutathione participates in cellular protection, detoxification enzymes and the management of oxidative stress.
ALA has also been investigated for its ability to help regenerate oxidised forms of vitamins C and E under experimental conditions.[1,2]
These mechanisms are biologically interesting, but taking an antioxidant supplement does not guarantee protection against every disease associated with oxidative stress.
2. Contributes to mitochondrial energy metabolism
Mitochondria convert energy from carbohydrates, fats and amino acids into ATP, the body’s usable cellular energy.
Alpha-lipoic acid functions as a cofactor for several mitochondrial enzyme complexes involved in energy metabolism. This makes it important to normal cellular function.
However, taking supplemental alpha-lipoic acid does not automatically produce a noticeable increase in energy. Evidence is insufficient to describe it as a treatment for fatigue in otherwise healthy people.
3. May support glucose metabolism
Alpha-lipoic acid has been investigated for its effects on glucose uptake, insulin sensitivity and markers of blood-glucose control.
A 2018 systematic review and meta-analysis reported improvements in some glucose-homeostasis and lipid measurements following ALA supplementation. A separate 2019 meta-analysis also suggested possible improvements in selected glycaemic and inflammatory markers.[3,4]
However, effects varied between studies, and the improvements were not consistent across every measurement or population. Alpha-lipoic acid should therefore not be described as “normalising” glucose or insulin levels.
It must not replace:
-
Prescribed diabetes medication
-
Blood-glucose monitoring
-
An appropriate diet
-
Physical activity
-
Medical care
Because ALA may influence blood glucose, people using insulin or glucose-lowering medication should consult their healthcare professional before taking it.
4. May help with symptoms of diabetic peripheral neuropathy
Diabetic peripheral neuropathy is nerve damage associated with diabetes. It may cause:
-
Burning sensations
-
Tingling
-
Numbness
-
Pain
-
Altered sensitivity in the hands or feet
This is the clinical area in which alpha-lipoic acid has been studied most extensively.
A 2023 systematic review and meta-analysis of ten randomised trials involving 1,242 participants found that oral ALA produced improvements in some symptom scores and patient satisfaction. However, it did not show favourable results for every neurological or nerve-conduction measurement.[5]
A 2024 Cochrane review reached a more cautious conclusion. It found that ALA probably had little or no effect on neuropathy symptoms after six months when compared with placebo.[6]
These apparently different conclusions may reflect differences in study duration, outcome selection, dose and trial quality.
Overall, ALA may help some people with short-term sensory symptoms, but it has not been proven to reverse nerve damage or cure diabetic neuropathy.
People experiencing numbness, pain or burning sensations should seek medical assessment. Neuropathy can have several causes, including diabetes, vitamin deficiencies, thyroid disorders, medication effects and nerve compression.
5. Possible role in metabolic health and weight management
Researchers have studied ALA in relation to body weight, inflammation, lipid levels and cardiovascular risk markers.
Some meta-analyses report small improvements in selected metabolic measurements. An updated systematic review found modest reductions in measurements related to body weight, although the size and clinical importance of these effects varied.[3,7]
ALA should not be promoted as a weight-loss medicine or a replacement for a sustainable diet and exercise programme.
Does Alpha-Lipoic Acid Protect Cell Membranes?
Alpha-lipoic acid is often described as functioning in both lipid- and water-associated environments. This has led to interest in its potential ability to support cellular membranes and tissues vulnerable to oxidative stress.
Its interaction with antioxidant systems may contribute to cellular protection under certain conditions. However, claims that a supplement directly “repairs” cell membranes or protects the myelin sheath in humans go beyond the current clinical evidence.
ALA should not be presented as a treatment for demyelinating or neurological disorders.
Can Alpha-Lipoic Acid Treat Multiple Sclerosis?
Alpha-lipoic acid has been studied experimentally in multiple sclerosis because of its potential antioxidant and anti-inflammatory properties.
Early clinical research has explored whether it might influence brain-volume loss, mobility or inflammatory activity. However, the evidence remains preliminary, and ALA has not been established as a treatment for multiple sclerosis.
People with multiple sclerosis should not replace disease-modifying therapy with ALA or any other supplement. Any supplementary use should be discussed with the specialist responsible for their treatment.
Does Alpha-Lipoic Acid Help Diabetic Retinopathy?
Persistently elevated blood glucose can damage blood vessels in the retina, making regular eye screening essential for people with diabetes.
ALA has been investigated because oxidative stress may contribute to diabetic complications. However, there is currently insufficient clinical evidence that oral ALA prevents or treats diabetic retinopathy.
It should not replace:
-
Blood-glucose management
-
Blood-pressure management
-
Regular diabetic eye screening
-
Ophthalmological treatment
An earlier randomised trial investigating ALA for the prevention of diabetic macular oedema did not establish a clear protective treatment effect.[8]
Does Alpha-Lipoic Acid Inhibit Cancer?
Laboratory and animal studies have investigated ALA’s effects on oxidative stress, signalling pathways and cancer cells.
These findings do not demonstrate that ALA prevents, treats or cures cancer in humans.
Antioxidants may also interact with certain cancer treatments. Anyone receiving chemotherapy, radiotherapy or another anticancer treatment should consult their oncology team before taking ALA or high-dose antioxidant supplements.
ALA should not be marketed as inhibiting cancer without robust human clinical evidence and an appropriately authorised health claim.
Can Alpha-Lipoic Acid Detoxify Mercury or Other Heavy Metals?
Alpha-lipoic acid can interact with some metal ions in laboratory models, and its potential role in heavy-metal toxicity has been discussed in scientific reviews.[9]
However, this does not mean that taking an ALA supplement is a safe or proven “mercury detox.”
Heavy-metal poisoning requires:
-
Appropriate diagnostic testing
-
Identification and removal of the exposure source
-
Medical assessment
-
Clinically supervised treatment where necessary
ALA should not replace approved chelation therapy. Attempting to treat suspected mercury or other heavy-metal toxicity without medical supervision may be dangerous.
How Much Alpha-Lipoic Acid Is Commonly Used?
The most frequently studied oral amount for diabetic neuropathy is approximately 600 mg daily.[5]
Some studies have used 1,200–1,800 mg daily, but a higher amount does not necessarily provide a better balance of benefits and adverse effects.
The recommendation sometimes made online to take 600 mg three times daily should not be treated as suitable general advice. A total daily amount of 1,800 mg is a high supplemental intake and should only be considered under appropriate professional supervision.
Always follow the directions provided with the individual product unless a qualified healthcare professional advises otherwise.
Should Alpha-Lipoic Acid Be Taken With Food?
Alpha-lipoic acid is commonly advised to be taken on an empty stomach because food may reduce or delay its absorption.
However, taking it without food may increase nausea or stomach discomfort in some people. If the product directions permit it, someone who experiences digestive discomfort should seek advice from a pharmacist or healthcare professional rather than continuing an unsuitable regimen.
Shifa Supplements Alpha Lipoic Acid Powder
For those who prefer a powder rather than capsules, Shifa Supplements Alpha Lipoic Acid Powder provides a high-purity, single-ingredient ALA formula.
Product highlights
-
100 g of alpha-lipoic acid powder
-
1,000 mg per labelled serving
-
Approximately 100 servings
-
No fillers, binders or unnecessary additives
-
No added sugar
-
Vegan
-
Non-GMO
-
Halal certified
-
Manufactured in the United Kingdom in a GMP-certified facility
-
Measuring scoop included
Because the product provides a high-strength 1,000 mg serving, it is important to follow the label directions carefully. A digital scale may provide more accurate measurement than relying solely on volume.
People taking medication or managing diabetes, thyroid disease, liver disease, kidney disease or another medical condition should consult a healthcare professional before using the product.
Shop Shifa Supplements Alpha Lipoic Acid Powder
Food supplements should not be used as a substitute for a varied, balanced diet and a healthy lifestyle.
Possible Side Effects
Alpha-lipoic acid is generally well tolerated at commonly studied amounts, but possible adverse effects include:
-
Nausea
-
Vomiting
-
Abdominal discomfort
-
Heartburn
-
Headache
-
Dizziness
-
Skin rash
-
Lowered blood glucose
A systematic review of randomised clinical trials found no overall increase in adverse events compared with control groups, although tolerability can vary between individuals.[10]
Rare cases of insulin autoimmune syndrome have been reported in association with ALA. This condition can cause episodes of low blood glucose, particularly in genetically susceptible individuals.[11]
Who Should Speak to a Healthcare Professional Before Taking ALA?
Professional advice is especially important if you:
-
Have diabetes or experience low blood glucose
-
Use insulin or other glucose-lowering medicines
-
Have thyroid disease or take thyroid medication
-
Are receiving chemotherapy or radiotherapy
-
Have liver or kidney disease
-
Regularly consume excessive amounts of alcohol
-
Are pregnant, planning pregnancy or breastfeeding
-
Are considering ALA for a diagnosed neurological condition
-
Are taking several medicines or supplements
People with prolonged excessive alcohol consumption may be at risk of thiamine deficiency. High-dose ALA should not be used in this situation without professional advice.
The Bottom Line
Alpha-lipoic acid is a naturally occurring compound involved in mitochondrial energy metabolism and cellular antioxidant systems.
Its most extensively studied clinical application is diabetic peripheral neuropathy. Some research suggests that oral ALA may improve certain sensory symptoms, but longer-term evidence is mixed, and it has not been proven to reverse nerve damage.[5,6]
ALA may also produce modest changes in glucose, insulin and selected metabolic markers, but it must not replace prescribed treatment, blood-glucose monitoring or lifestyle management.[3,4]
Claims that alpha-lipoic acid treats cancer, multiple sclerosis, diabetic retinopathy or mercury toxicity are not supported by sufficient human clinical evidence.
For most supplement users, more is not necessarily better. Anyone managing a medical condition or taking medication should consult an appropriately qualified healthcare professional before using alpha-lipoic acid.
This article is provided for general educational purposes and is not a substitute for personalised medical advice, diagnosis or treatment.
References
-
Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radical Biology and Medicine. 1995;19(2):227–250. PubMed PMID: 7649494
-
Tibullo D, Li Volti G, Giallongo C, et al. Biochemical and clinical relevance of alpha-lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential. Inflammation Research. 2017. PubMed PMID: 28676917
-
Akbari M, Ostadmohammadi V, Tabrizi R, et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomised controlled trials. 2018. PubMed PMID: 29990473
-
Rahimlou M, Asadi M, Banaei Jahromi N, Mansoori A. Alpha-lipoic acid supplementation effect on glycaemic and inflammatory biomarkers: a systematic review and meta-analysis. 2019. PubMed PMID: 31221283
-
Hsieh RY, Huang TJ, Yeh WL, et al. Effects of oral alpha-lipoic acid treatment on diabetic polyneuropathy: a meta-analysis and systematic review. Nutrients. 2023;15(16):3634. PubMed PMID: 37630823
-
Baicus C, et al. Alpha-lipoic acid for diabetic peripheral neuropathy. Cochrane Database of Systematic Reviews. 2024. PubMed PMID: 38205823
-
Vajdi M, et al. Alpha-lipoic acid supplementation and measures of obesity: an updated systematic review and dose-response meta-analysis of randomised controlled trials. 2020. PubMed PMID: 32091656
-
Haritoglou C, Gerss J, Hammes HP, Kampik A, Ulbig MW. Alpha-lipoic acid for the prevention of diabetic macular oedema. 2011. PubMed PMID: 21811051
-
Patrick L. Mercury toxicity and antioxidants: Part 1—role of glutathione and alpha-lipoic acid in the treatment of mercury toxicity. Alternative Medicine Review. 2002;7(6):456–471. PubMed PMID: 12495372
-
Fogacci F, Rizzo M, Krogager C, et al. Safety evaluation of alpha-lipoic acid supplementation: a systematic review and meta-analysis of randomised placebo-controlled clinical studies. Antioxidants. 2020;9(10):1011. PubMed PMID: 33086555
-
Gatti M, Ippoliti I, Poluzzi E, et al. Assessment of adverse reactions to alpha-lipoic acid-containing products using spontaneous reporting systems. 2021. PubMed PMID: 32778460